A Phase 2 Randomized, Double-blind, Placebo-controlled, 3-arm, Parallel-design Study of the Efficacy and Safety of VX-150 for Acute Pain Following Bunionectomy
Phase of Trial: Phase II
Latest Information Update: 08 Jan 2018
At a glance
- Drugs VX 150 (Primary) ; Hydrocodone/paracetamol
- Indications Pain
- Focus Therapeutic Use
- Sponsors Vertex Pharmaceuticals
- 03 Jan 2018 Status changed from recruiting to completed.
- 05 Jul 2017 Status changed from not yet recruiting to recruiting.
- 04 Jul 2017 New trial record